Federated Hermes, Inc. Jazz Pharmaceuticals PLC Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Federated Hermes, Inc. holds 31,614 shares of JAZZ stock, worth $3.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,614

Previous 113,017 72.03%

Holding current value

$3.83 Million

Previous $12.1 Million 70.79%

% of portfolio

0.01%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.57 - $116.37 $8.19 Million - $9.47 Million	-81,403 Reduced 72.03%	31,614 $3.52 Million
Q2 2024 Aug 08, 2024	SELL	$103.94 - $118.98 $1.58 Million - $1.81 Million	-15,188 Reduced 11.85%	113,017 $12.1 Million
Q1 2024 May 14, 2024	BUY	$115.19 - $132.77 $1.01 Million - $1.16 Million	8,732 Added 7.31%	128,205 $15.4 Million
Q4 2023 Jan 31, 2024	SELL	$114.26 - $136.0 $475,550 - $566,032	-4,162 Reduced 3.37%	119,473 $14.7 Million
Q3 2023 Nov 13, 2023	BUY	$122.0 - $145.31 $13.8 Million - $16.5 Million	113,380 Added 1105.61%	123,635 $16 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $857 - $1,030	7 Added 0.07%	10,255 $1.27 Million
Q1 2023 May 08, 2023	SELL	$133.98 - $160.47 $9,378 - $11,232	-70 Reduced 0.68%	10,248 $1.5 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $53,574 - $66,018	413 Added 4.17%	10,318 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $92,284 - $117,500	-729 Reduced 6.86%	9,905 $1.32 Million
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $48,140 - $57,344	-340 Reduced 3.1%	10,634 $1.66 Million
Q1 2022 May 13, 2022	SELL	$129.64 - $160.7 $274,577 - $340,362	-2,118 Reduced 16.18%	10,974 $1.71 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $58,376 - $70,941	-487 Reduced 3.59%	13,092 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $11.6 Million - $16.6 Million	-89,907 Reduced 86.88%	13,579 $1.77 Million
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $656,980 - $764,508	-4,101 Reduced 3.81%	103,486 $18.4 Million
Q1 2021 May 13, 2021	SELL	$150.19 - $173.5 $1.04 Million - $1.2 Million	-6,904 Reduced 6.03%	107,587 $17.7 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $169,836 - $199,215	1,207 Added 1.07%	114,491 $18.9 Million
Q3 2020 Nov 12, 2020	SELL	$105.46 - $144.13 $871,521 - $1.19 Million	-8,264 Reduced 6.8%	113,284 $16.2 Million
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $579,533 - $738,227	6,057 Added 5.24%	121,548 $13.4 Million
Q1 2020 May 13, 2020	BUY	$87.74 - $152.74 $616,812 - $1.07 Million	7,030 Added 6.48%	115,491 $11.5 Million
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $1.28 Million - $1.67 Million	-10,892 Reduced 9.13%	108,461 $16.2 Million
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $1 Million - $1.15 Million	-8,024 Reduced 6.3%	119,353 $15.3 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $6.39 Million - $7.35 Million	50,895 Added 66.55%	127,377 $18.2 Million
Q1 2019 May 10, 2019	BUY	$121.81 - $142.95 $7.93 Million - $9.3 Million	65,091 Added 571.42%	76,482 $10.9 Million
Q4 2018 Feb 13, 2019	SELL	$115.94 - $166.74 $2.46 Million - $3.54 Million	-21,235 Reduced 65.09%	11,391 $1.41 Million
Q3 2018 Nov 13, 2018	BUY	$161.01 - $180.57 $3.45 Million - $3.87 Million	21,426 Added 191.3%	32,626 $5.49 Million
Q2 2018 Aug 10, 2018	SELL	$146.33 - $183.18 $204,862 - $256,452	-1,400 Reduced 11.11%	11,200 $1.93 Million
Q1 2018 May 09, 2018	SELL	$135.59 - $157.16 $894,894 - $1.04 Million	-6,600 Reduced 34.38%	12,600 $1.9 Million
Q3 2017 Nov 13, 2017	BUY	$142.62 - $155.6 $2.74 Million - $2.99 Million	19,200	19,200 $2.81 Million

Others Institutions Holding JAZZ

# of Institutions

512

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.6B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Jazz Pharmaceuticals PLC Transaction History